Harbaugh Is Critical On Number Of Preseason Games Mets Shift Promotional Philosophy NFL Cites Lack Of Cooperation In Brown Case Kendrick To Blame For D-backs' Struggles? Gateway Addition Highlights '17 IndyCar Schedule NFL Forms New Chairmen's Committee Atallah Brushes Off Norman's NFLPA Criticism Nick Kyrgios Seen As The Future Of Tennis WTA Personnel Could Be Deposed In Lawsuit League Notes
SBD/March 25, 2013/Leagues and Governing Bodies
MLB Sues South Florida Biogenesis Clinic; Weiner Points To Braun Case
Published March 25, 2013
END GAME? In Milwaukee, Tom Haudricourt wrote the suit is “being viewed as another attempt by MLB to get cooperation in its investigation of the clinic.” The league “does not have subpoena power and otherwise would need documentary evidence or witness testimony to suspend a player for using PEDs.” MLBPA Exec Dir Michael Weiner on Friday said, "They believe it necessary to enforce their contract with us, the Joint Drug Agreement. The allegations are those individuals interfered with that contract and we'll see where the lawsuit goes.” Weiner said MLB is "disappointed" they lost the case involving Brewers LF Ryan Braun. He added, "But they're professionals. ... We've lost cases that we fought and were disappointed, and players ended up sitting out for 50 games. I expect MLB is going to be professional with respect to all of the players whose names have surfaced in connection with the Biogenesis thing. Ryan is included” (JSONLINE.com, 3/22). The GLOBE & MAIL’s Jeff Blair wrote the suit “seems to be a thinly veiled attempt to extract a pound of flesh from Ryan Braun.” MLB Commissioner Bud Selig has “chosen a strange time to pick a fight that is not a legal slam-dunk, a little more than a week from the start of the regular season.” Selig also is “taking a run at the star player on the team his family used to own, the Brewers, in a city in which he still lives, Milwaukee.” Blair wrote what the league “really wants is documentation that will allow it to hammer Braun.” MLB must be “doing boffo business for Selig to be this emboldened” (GLOBE & MAIL, 3/23).